Aurora Cannabis Inc.

NasdaqCM:ACB Stock Report

Market Cap: US$237.4m

Aurora Cannabis Dividends and Buybacks

Dividend criteria checks 0/6

Aurora Cannabis does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-11.0%

Buyback Yield

Total Shareholder Yield-11.0%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Aurora Cannabis: Revving Up To Profitability

Aug 08

Aurora launches new cannabis products for adult and medical-use

Oct 17

Aurora Cannabis further strengthens its balance sheet by repurchasing ~US$23M of convertible notes

Oct 07

Aurora Cannabis Q4 2022 Earnings Preview

Sep 19

Aurora Cannabis: Don't Let Your Money Go Up In Smoke

Aug 25

Why Did Aurora Cannabis Stock Crash In May; Can It Recover?

Jun 13

Recent Developments Do Not Change Our Stance On Aurora Cannabis

May 13

Aurora Cannabis: A Train Wreck Desperate For Help

May 05

Aurora Cannabis: The Fallen Pot Giant That Still Can't Find Its Way

Feb 17

Aurora Cannabis Vs. HEXO: Which Is The Better Cannabis Stock?

Dec 17

Tilray Vs. Aurora Cannabis: How To Compare These Cannabis Stocks

Oct 11

Aurora Cannabis: Investors Should Have No Confidence In This Company

Sep 28

Is Aurora Cannabis Stock A Buy Or Sell Before Upcoming Earnings? Buy The U.S. Opportunity

Sep 16

Aurora Cannabis Is A Pass For Now, Although We Are Bullish On The Industry

Jun 05

Aurora Cannabis: Extreme Downside Case Averted

Feb 02

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if ACB's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ACB's dividend payments have been increasing.


Dividend Yield vs Market

Aurora Cannabis Dividend Yield vs Market
How does ACB dividend yield compare to the market?
SegmentDividend Yield
Company (ACB)n/a
Market Bottom 25% (US)1.4%
Market Top 25% (US)4.2%
Industry Average (Pharmaceuticals)2.4%
Analyst forecast (ACB) (up to 3 years)n/a

Notable Dividend: Unable to evaluate ACB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ACB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate ACB's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as ACB has not reported any payouts.


Discover strong dividend paying companies